Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria (PKU) next year, after reporting solid proof-of-concept data. PKU is a rare ...
Newborn screening (NBS) is every child’s birthright ... Galactosemia (GALT) and PKU was found to be 1:2735, 1:4102, 1:414, 1:41027 and 1:20513 respectively in a government hospital.